Difference between revisions of "Coronavirus testing"
(a start) |
(Those having early, special access to coronavirus testing include entire NBA teams and congressmen.) |
||
| Line 1: | Line 1: | ||
'''Coronavirus testing''' is relatively easy, non-invasive, affordable, and yet unavailable in most of the [[United States]] as of March 18, 2019, except to professional athletes, [[Hollywood]] actors and actresses, and high-level politicians. The [[FDA]] and [[CDC]] have impeded access to testing by most Americans despite the ability of private companies to mass-produce such tests. | '''Coronavirus testing''' is relatively easy, non-invasive, affordable, and yet unavailable in most of the [[United States]] as of March 18, 2019, except to professional athletes, [[Hollywood]] actors and actresses, and high-level politicians. The [[FDA]] and [[CDC]] have impeded access to testing by most Americans despite the ability of private companies to mass-produce such tests. | ||
| + | |||
| + | Those having early, special access to coronavirus testing include entire [[NBA]] teams and congressmen. | ||
Insurance companies have balked at providing coverage for treatment of coronavirus, which provides a further incentive for tests to be withheld from the general public. | Insurance companies have balked at providing coverage for treatment of coronavirus, which provides a further incentive for tests to be withheld from the general public. | ||
Revision as of 01:43, March 19, 2020
Coronavirus testing is relatively easy, non-invasive, affordable, and yet unavailable in most of the United States as of March 18, 2019, except to professional athletes, Hollywood actors and actresses, and high-level politicians. The FDA and CDC have impeded access to testing by most Americans despite the ability of private companies to mass-produce such tests.
Those having early, special access to coronavirus testing include entire NBA teams and congressmen.
Insurance companies have balked at providing coverage for treatment of coronavirus, which provides a further incentive for tests to be withheld from the general public.
Convenient drive-through testing has been available in South Korea, which has more of a free market in health care, long before the United States.